Use of glycopyrrolate and other anticholinergic medications for sialorrhea in children with cerebral palsy.
Fifty-four parents/caretakers of children with cerebral palsy were surveyed regarding their use of antisialorrheic medication for excessive drooling. Glycopyrrolate was used by 37 of 41 respondents, with significant improvement in drooling noted in the vast majority (95%) of cases as indicated by a five-point rating scale. Side effects (dry mouth, thick secretions, urinary retention, or flushing) surfaced in almost half (44%) of the patients but necessitated discontinuation of pharmacologic treatment in less than a third. While larger clinical studies are needed, our preliminary data indicate a trial of glycopyrrolate should be considered in children with cerebral palsy where drooling is a significant problem.
Bachrach
S J
SJ
Department of Pediatrics, duPont Hospital for Children, Wilmington, Delaware 19803, USA.
Walter
R S
RS
Trzcinski
K
K
D002547:Cerebral Palsy / Q000503:physiopathology*; D002648:Child; D002675:Child, Preschool; D004305:Dose-Response Relationship, Drug; D005260:Female; D006024:Glycopyrrolate / Q000008:administration & dosage* / Q000009:adverse effects; D006801:Humans; D008297:Male; D012798:Sialorrhea / Q000188:drug therapy / Q000209:etiology* / Q000517:prevention & control
D006024:Glycopyrrolate